Suling Xu

Prof. Suling Xu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Computers in Biology and Medicine
Verified
Journal Article
Open access
CXChao Xin
Chao Xin
ZLzhifang liu
zhifang liu
KZKeyu Zhao
Keyu Zhao
LMLinlin Miao
Linlin Miao
YMYizhao Ma
Yizhao Ma
HCHaijiang Chen
Haijiang Chen
Use of artificial intelligence to identify dermoscopic images has brought major breakthroughs in recent years to the early diagnosis and early treatment of skin cancer, the incidence of which is increasing year by year worldwide and poses a great threat to human health. Achievements have been made in the research of skin cancer image classification by using the deep backbone of the convolutional neural network (CNN). This approach, however, only extracts the features of small objects in the image, and cannot locate the important parts. As a result, researchers of the paper turn to vision transformers (VIT) which has demonstrated powerful performance in traditional classification tasks. The self-attention is to improve the value of important features and suppress the features that cause noise. Specifically, an improved transformer network named SkinTrans is proposed. To verify its efficiency, a three step procedure is followed. Firstly, a VIT network is established to verify the effectiveness of SkinTrans in skin cancer classification. Then multi-scale and overlapping sliding windows are used to serialize the image and multi-scale patch embedding is carried out which pay more attention to multi-scale features. Finally, contrastive learning is used which makes the similar data of skin cancer encode similarly so that the encoding results of different data are as different as possible. The experiment is carried out based on two datasets, namely (1) HAM10000: a large dataset of multi-source dermatoscopic images of common skin cancers; (2)A clinical dataset of skin cancer collected by dermoscopy. The model proposed has achieved 94.3% accuracy on HAM10000 and 94.1% accuracy on our datasets, which verifies the efficiency of SkinTrans. The transformer network has not only achieved good results in natural language but also achieved ideal results in the field of vision, which also lays a good foundation for skin cancer classification based on multimodal data. This paper is convinced that it will be of interest to dermatologists, clinical researchers, computer scientists and researchers in other related fields, and provide greater convenience for patients.

1 December 2021 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
SZSongwei Zhao
Songwei Zhao
PWPengjun Wang
Pengjun Wang
Ali Asghar HeidariAli Asghar Heidari
Ali Asghar Heidari
Huiling ChenHuiling Chen
Huiling Chen
WHWenming He
Wenming He
SXSuling Xu
Suling Xu

4 August 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
LRLili Ren
Lili Ren
DZDong Zhao
Dong Zhao
XZXuehua Zhao
Xuehua Zhao
WCWeibin Chen
Weibin Chen
LLLingzhi Li
Lingzhi Li
SXSuling Xu
Suling Xu

28 February 2024 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
SXSuling Xu
Suling Xu
QWQingqing Wang
Qingqing Wang
Wenxue MaWenxue Ma
Wenxue Ma

22 February 2026 in Cancer Letters
Verified
Journal Article
Open access
SXSuling Xu
Suling Xu
ZHZhixing Huang
Zhixing Huang
YLYanjun Li
Yanjun Li
LLLingeng Lu
Lingeng Lu
Wenxue MaWenxue Ma
Wenxue Ma
Melanoma remains the most lethal form of skin cancer despite major advances in targeted and immune-based therapies. Biomarkers now play central roles in diagnosis, risk stratification, therapeutic selection, and disease monitoring; however, their clinical integration remains inconsistent. This review synthesizes the evolving biomarker landscape across genetic (e.g., BRAF, NRAS, KIT, TERT, NF1, CDKN2A), immune (PD-L1, LAG-3, TIGIT, TILs, TMB), proteomic (S100B, MMPs, signaling signatures), and digital/imaging biomarkers (AI-assisted dermo copy, spatial and multiplex profiling). We highlight subtype-specific differences in mucosal, acral, and uveal melanoma, where biomarker patterns and therapeutic responses diverge markedly from those of cutaneous disease. Liquid biopsy approaches, including ctDNA, methylation signatures, and extracellular vesicles, are evaluated for minimal residual disease detection and resistance monitoring. To advance clinical translation, we propose a standardized, stepwise diagnostic therapeutic framework integrating tissue- and blood-based biomarkers with AI-enabled imaging to support personalized management in both adjuvant and metastatic settings. Key translational enablers include assay harmonization (PD-L1, TMB, ctDNA), evidence-tiered validation, and pragmatic clinical trials incorporating biomarker-driven endpoints. Addressing cost, accessibility, and data ethics will be essential for biomarker-guided precision oncology to become a sustainable clinical reality across diverse health systems.

1 February 2023 in International Wound Journal
Verified
Journal Article
Open access
YMYizhao Ma
Yizhao Ma
ZLZhifang Liu
Zhifang Liu
LMLinLin Miao
LinLin Miao
XJXinyu Jiang
Xinyu Jiang
HRHongyu Ruan
Hongyu Ruan
SXSuling Xu
Suling Xu
Pathological scarring is an abnormal outcome of wound healing, which often manifests as excessive proliferation and transdifferentiation of fibroblasts (FBs), and excessive deposition of the extracellular matrix. FBs are the most important effector cells involved in wound healing and scar formation. The factors that promote pathological scar formation often act on the proliferation and function of FB. In this study, we describe the factors that lead to abnormal FB formation in pathological scarring in terms of the microenvironment, signalling pathways, epigenetics, and autophagy. These findings suggest that understanding the causes of abnormal FB formation may aid in the development of precise and effective preventive and treatment strategies for pathological scarring that are associated with improved quality of life of patients.